Dow Rohm and Haas

DOW chemical company The year 2009 was the most active an challenging year for Dow in its whole history. It was the turning point for the transformation to the leading global force chemical and advanced materials Company. On April 1 2009 DOW at last effected the acquisition of specialty chemicals maker Rohm and Haas subsequently eight months fight. On July 10 2008 DOW pronounced to pay $78 per share to buy Rohm and Haas (current nervous strain price on 9 July, $44, 83) because they expected more than than $7 one thousand thousand in pretax process from the joint venture, K-DOW, with a state owned capital of Kuwait company.Due to the global pecuniary crisis, the decrease of the oil prices and the governmental military rank for the deal as too risky the Kuwait Company distinguish their $17. 4 billion offer in December 2008. Dow was now indisposed to pay the $15. 3 billion for Rohm and Haas and consequently tried to delay the process. With this situation, the predicament of DOW was perfect, a global economic meltdown and a promise which DOW was non able to finish because of a deal break. The whole economy changed after the pronouncement in July that the spot largest chemical company would like to by Rohm and Haas.Stock prices of chemical companies increased immense and the shareholder of Rohm and Haas expect a large profit from their shares especially in the ongoing global downturn, touch the downslope values to the bare bone. Rohm and Haas forced DOW to finish the promised acquisition entirely DOW never got a specific plan how to handle this complex and importantly changed situation. Just an email from the chairman of DOW explained that it would be better to wait savings bank June 2009 in order to finish the deal.After they heard that Dow invested in varied other projects it was simply too much for Rohm and Haas, as they could not apprehend why other deals were made but the acquisition was still delayed, so they started a litigation to enforc e the merger. Rohm and Haas and DOW conducted several meeting to find a way to resolve the situation, but without any success and to the great mortification of Rohm and Haas as their expectations were not met at all. Analysts said It was a CLASH OF TITANS. finance Projects clinical Research Case- DOW Chemical CompanySilke Rahden In terms of the second half of 2008 and beginning of 2009 we notice a dramatically decrease of the DOW stock price. Well, it is in the middle of the financial crisis in the USA but the more important deal which caused the decline was the acquisition of Rohm and Haas, pronounced in July 2008 and finally finished in April 2009. During this time the stock prices slide into free worsening/ drop to the pits from $32,52 (July 2008) to $8,81 (April 2009). The absolutely low point was on 30 bump into 2009 with $8. 30 per share.The main reason for the death point, in addition to the financial crisis, was the finish of the acquisition of Rohm and Haas after eight m onths up and downs. Income Statement pay Projects Clinical Research Case- DOW Chemical Company Silke Rahden References http//finance. yahoo. com/q/is? s=DOW+Income+Statement&yearly http//phx. corporate-ir. net/phoenix. zhtml? c=80099&p=irolstockcalculator&t=Calc&control_type=256&control_ http//crisisexperts. blogspot. com/2009/02/dowrohm-and-haas-acquisition-crisis. html Finance Projects Clinical Research Case- DOW Chemical Company Silke Rahden